Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 73 views

    MSDS-0284 MSDS For COVID-19 Rapid Test

    Uploaded by

    jefferson rivera nares
    This document provides a material safety data sheet for a COVID-19 rapid test. It details information about the test such as the manufacturer, ingredients, safety hazards, storage requirements, and disposal. The test is for qualitative detection of COVID-19 antibodies in whole blood, serum, or plasma.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    MSDS-0284 MSDS For COVID-19 Rapid Test

    Uploaded by

    jefferson rivera nares
    73 views3 pages
    This document provides a material safety data sheet for a COVID-19 rapid test. It details information about the test such as the manufacturer, ingredients, safety hazards, storage requirements, and disposal. The test is for qualitative detection of COVID-19 antibodies in whole blood, serum, or plasma.

    Original Description:

    MSDS-0284 MSDS for COVID-19 Rapid Test

    Original Title

    MSDS-0284 MSDS for COVID-19 Rapid Test

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document provides a material safety data sheet for a COVID-19 rapid test. It details information about the test such as the manufacturer, ingredients, safety hazards, storage requirements, and disposal. The test is for qualitative detection of COVID-19 antibodies in whole blood, serum, or plasma.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    73 views3 pages

    MSDS-0284 MSDS For COVID-19 Rapid Test

    Uploaded by

    jefferson rivera nares
    This document provides a material safety data sheet for a COVID-19 rapid test. It details information about the test such as the manufacturer, ingredients, safety hazards, storage requirements, and disposal. The test is for qualitative detection of COVID-19 antibodies in whole blood, serum, or plasma.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 3

    杭州博拓生物科技股份有限公司 Hangzhou Biotest Biotech Co., Ltd. 文件编号 Document No.

    ：MSDS-0284
    MSDS for COVID-19 Rapid Test 第 1页共 3 页 Page 1 of 3

    MSDS for COVID-19 Rapid Test

    I .1.Indentification of the product


    Product Name: COVID-19 Rapid Test
    Brand: RightSign®

    I .2.Use of the preparation


    The COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid
    chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to
    SARS-CoV-2 in human whole blood, serum, or plasma as an aid in the diagnosis of
    primary and secondary COVID-19 infections.

    I .3.Company Indentifiation
    Company: Hangzhou Biotest Biotech Co., Ltd.
    Address: #17 Futai Road, Zhongtai Street , Yuhang District , Hangzhou. P.R.China.
    311121
    Tel: 0086-571-89058016
    Fax:0086-571-88633388
    E-mail: info@biotests.com.cn
    I .4.Emergency telephone No.
    Emergency telephone: 0086-571-89058016

    II Information of Ingredients
    Sodium Azide Concentration: = <0.02% (7.5ng/test)
    CAS#: 26628-22-8

    III Hazards Indentification


    Not dangerous preparation

    IV First aid measures


    First-aid personnel: N/A
    After inhalation: N/A
    After skin contact: N/A
    After eye contact: N/A
    After swallowing: N/A

    V. Fire-fighting measures
    Inflammable in contact with flames, not explosive.
    Extinguishing media: water or foam

    VI Accidental release measure


    N/A
    版本号 Version：02 修订号 Revision：00
    杭州博拓生物科技股份有限公司 Hangzhou Biotest Biotech Co., Ltd. 文件编号 Document No.：MSDS-0284
    MSDS for COVID-19 Rapid Test 第 2页共 3 页 Page 2 of 3

    VII. 1. Handling
    Good Laboratory Practices(disposal gloves)

    VII. 2. Storage
    Store in a dry place at +2℃ to +30℃
    Avoid storage near to heat sources
    Accessible only for authorized persons

    VIII. Exposure controls/personal protection


    Specimen collection and preparation : all the specimens should be considered potentially
    hazardous and handled in the same manner as an infectious agent.
    Use disposal gloves.

    IX. Physical and chemical properties


    Form: Solid reaction strip that could be placed into a plastic cassette depending on the
    format used.
    Colour: White solid with red lines.
    Odour: N/A
    pH value: N/A
    Melting point: N/A
    Ignition temperature: N/A
    Flash point: N/A
    Explosion limits: N/A
    Density: N/A

    X. Stability and reactivity


    1. Stable
    2. Conditions to be avoided: Strong heating, direct contact with flames.
    3. Substances to be avoided: only use provided diluent for sample dilution

    XI. Toxicological information


    N/A

    XII. Ecological information


    The COVID-19 Rapid Test should be discarded in a proper biohazard container after
    testing.

    XIII. Disposal considerations


    After testing, the COVID-19 Rapid Test must be disposed of compliance with the
    respective national regulations.

    XIV. Transport information


    Not dangerous preparations, not required transport regulation.
    版本号 Version：02 修订号 Revision：00
    杭州博拓生物科技股份有限公司 Hangzhou Biotest Biotech Co., Ltd. 文件编号 Document No.：MSDS-0284
    MSDS for COVID-19 Rapid Test 第 3页共 3 页 Page 3 of 3

    XV. Regulatory information


    This product does not require special labeling, in accordance with the appropriate EC
    directives.

    This product is for in vitro diagnostic use therefore must compile with the European
    Directive 98/79/EC bearing the CE label prior to the placing on the market.

    XVI. Other information


    For professional in vitro Diagnostic use only. Consult instructions for use.

    References:
    1. REGULATION (EC) No 1907/2006
    2. REGULATION (EC) No 1272/2008
    3. IVDD 98/79/EC
    4. World Health Organization (WHO). WHO Statement Regarding Cluster of Pneumonia
    Cases in Wuhan, China. Beijing: WHO; 9 Jan 2020.
    5. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res 2011;81:85-164.
    6. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019;
    17:181-192.
    7. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of
    coronaviruses. TrendsMicrobiol 2016;24:490-502.

    版本号 Version：02 修订号 Revision：00

    You might also like